After 4 weeks of Danshen treatment, the decreased expressions of COL2 and aggrecan were significantly restored and the increased MMP-3 level was concomitantly weakened in the Danshen IDD group. The gene discussed is MMP3; the disease is intervertebral disk degenerative disorder.